Eli Lilly and Company

Lian Zhu Liu

Tianwei Ma

Haizhen Zhang

Zhi Long Hu

Jingye Zhou

Xiaoqing Wang

Mi Zeng

Gang Liu

Michael Robert Wiley

Ruirui Li

Yu Chen

Xiang Wu

Jingyuan Wang

Huanhuan Wang

The invention discloses privacy protection query language PQL and system thereof, comprising PQL statement and system, the system comprises parsing module, query module and noise-injection module; the parsing module comprises lexical analyzer and syntactic analyzer; user inputs PQL statement according to predetermined semantic and syntactic rules, after parsing module receives the PQL statement, lexical analyzer performs error checks on the PQL statement, correct results are sent to syntactic analyzer; the syntactic analyzer performs grammatical and semantic checks on PQL statement, generates a mapping table and a parameter table with correct results; after receiving mapping table, the query module encapsulates the same into SQL statement, and verifies the encapsulated SQL statement; the noise-injection module obtains final query results of the query module, calculates noise injection sensitivity according to parameter table; the invention ensures the data privacy security and satisfies that the injected noise does not affect data availability.

Method to use privacy protection query language PQL to improve the security of shared date

A compound of the Formula (1) is below provided where R1-R5 are as described in the description and each '*' represents a chiral center. 

Cyclohexyl benzamide compounds

The present invention provides a compound of Formula (I) wherein X is selected from the group consisting of (CH)&#x2014; and CH&#x2014;CH(CH)&#x2014;; Q is selected from the group consisting of C(CH)and Formula (a); or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH. 

Imidazolidine compounds

The present invention provides a compound of Formula I   or

Cyclobutyl-imidazolidinone compounds

The present invention provides compounds of the Formula below wherein R, R1-R3 are as described herein; methods of treating patients for diabetes using the compounds, and processes for preparing the compounds.

Tetrahydropyranyl benzamide derivatives

The present invention provides compounds of the Formula (Ia) wherein R is selected from the group consisting of CH, CH(CH), CHCN, CHCHF, CHCF, (A), (B), (C), (D), (E), (F), CHCHOCH, and CHC(O)OCH(CH); Ris selected from the group consisting of CF, OCF, and Cl; Ris selected from the group consisting of H and F; or a pharmaceutically acceptable salt thereof. 

Growing community of inventors

Shanghai, China

Lian Zhu Liu